186
Views
3
CrossRef citations to date
0
Altmetric
Articles

Is Preoperative G-Tube Use Safe for Esophageal Cancer Patients?

, , , , , , , & show all
Pages 301-306 | Received 17 May 2019, Accepted 16 Jul 2019, Published online: 09 Aug 2019

References

  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30. Epub 2018/01/10. doi: 10.3322/caac.21442.
  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. Epub 2018/09/13. doi: 10.3322/caac.21492.
  • Huddy JR, Huddy FMS, Markar SR, Tucker O. Nutritional optimization during neoadjuvant therapy prior to surgical resection of esophageal cancer-a narrative review. Dis Esophagus. 2018;31(1):1–11. Epub 2017/10/13. doi: 10.1093/dote/dox110.
  • Short MW, Burgers KG, Fry VT. Esophageal cancer. Am Fam Phys. 2017;95(1):22–28. Epub 2017/01/12.
  • Reim D, Friess H. Feeding challenges in patients with esophageal and gastroesophageal cancers. Gastrointest Tumors. 2016;2(4):166–177. Epub 2016/07/13. PubMed PMID: 27403411; PubMed Central PMCID: PMCPMC4924457. doi: 10.1159/000442907.
  • Bozzetti F. Nutritional support in patients with oesophageal cancer. Support Care Cancer. 2010;18(S2):41–50. Epub 2009/06/25. doi: 10.1007/s00520-009-0664-9.
  • van Hagen P, Hulshof MCCM, van Lanschot JJB, Steyerberg EW, Henegouwen MI. V B, Wijnhoven BPL, Richel DJ, Nieuwenhuijzen GAP, Hospers GAP, Bonenkamp JJ. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366(22):2074–2084. Epub 2012/06/01. doi: 10.1056/NEJMoa1112088.
  • Mariette C, Dahan L, Mornex F, Maillard E, Thomas P-A, Meunier B, Boige V, Pezet D, Robb WB, Le Brun-Ly V, et al. Surgery alone versus chemoradiotherapy followed by surgery for stage I and II esophageal cancer: final analysis of randomized controlled phase III trial FFCD 9901. JCO. 2014;32(23):2416–2422. Epub 2014/07/02. doi: 10.1200/JCO.2013.53.6532.
  • Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJH, Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355(1):11–20. Epub 2006/07/11. doi: 10.1056/NEJMoa055531.
  • Adebahr S, Schimek-Jasch T, Nestle U, Brunner TB. Oesophagus side effects related to the treatment of oesophageal cancer or radiotherapy of other thoracic malignancies. Best Pract Res Clin Gastroenterol. 2016;30(4):565–580. Epub 2016/09/21. doi: 10.1016/j.bpg.2016.07.003.
  • Kassam Z, Wong RKS, Ringash J, Ung Y, Kamra J, DeBoer G, O'Brien M, Kim J, Loblaw DA, Wong S, et al. A phase I/II study to evaluate the toxicity and efficacy of accelerated fractionation radiotherapy for the palliation of dysphagia from carcinoma of the oesophagus. Clin Oncol (R Coll Radiol). 2008;20(1):53–60. Epub 2008/03/18.
  • Correia MI, Waitzberg DL. The impact of malnutrition on morbidity, mortality, length of hospital stay and costs evaluated through a multivariate model analysis. Clin Nutr. 2003;22(3):235–239. Epub 2003/05/27.
  • Jarvinen T, Ilonen I, Kauppi J, Salo J, Rasanen J. Loss of skeletal muscle mass during neoadjuvant treatments correlates with worse prognosis in esophageal cancer: a retrospective cohort study. World J Surg Onc. 2018;16(1):27. Epub 2018/02/13. PubMed PMID: 29433514; PubMed Central PMCID: PMCPMC5809976. doi: 10.1186/s12957-018-1327-4.
  • O'Gorman RB, Feliciano DV, Matthews KS, Matthews R, Bitondo CG, Mattox KL, et al. Correlation of immunologic and nutritional status with infectious complications after major abdominal trauma. Surgery. 1986;99(5):549–556. Epub 1986/05/01.
  • Windsor A, Braga M, Martindale R, Buenos P, Tepaske R, Kraehenbuehl L, Weimann A. Fit for surgery: an expert panel review on optmising patients prior to surgery, with a particular focus on nutrition. Surgeon. 2004;2(6):315–319. Epub 2005/02/17.
  • Gianotti L, Braga M, Nespoli L, Radaelli G, Beneduce A, Di Carlo V. A randomized controlled trial of preoperative oral supplementation with a specialized diet in patients with gastrointestinal cancer. Gastroenterol. 2002;122(7):1763–1770. Epub 2002/06/11.
  • Takeuchi H, Ikeuchi S, Kawaguchi Y, Kitagawa Y, Isobe Y, Kubochi K, Kitajima M, Matsumoto S. Clinical significance of perioperative immunonutrition for patients with esophageal cancer. World J Surg. 2007;31(11):2160–2167. Epub 2007/09/19. doi: 10.1007/s00268-007-9219-8.
  • Nakasaki H, Mitomi T, Tajima T, Ohnishi N, Fujii K. Gut bacterial translocation during total parenteral nutrition in experimental rats and its countermeasure. Am J Surg. 1998;175(1):38–43. Epub 1998/01/28.
  • Tucker AT, Gourin CG, Ghegan MD, Porubsky ES, Martindale RG, Terns DJ. Versus 'pull' percutaneous endoscopic gastrostomy tube placement in patients with advanced head and neck cancer. Laryngoscope. 2010;113(11):1898–1902. Epub 2003/11/07.
  • National Comprehensive Cancer Network. Esophageal and Esophagogastric Cancers (Version 1.2019) [April 7, 2019]. Available from: https://www.nccn.org/professionals/physician_gls/pdf/esophageal.pdf.
  • Ohnmacht GA, Allen MS, Cassivi SD, Deschamps C, Nichols FC, 3rd, Pairolero PC. Percutaneous endoscopic gastrostomy risks rendering the gastric conduit unusable for esophagectomy. Dis Esophagus. 2006;19(4):311–312. Epub 2006/07/27. doi: 10.1111/j.1442-2050.2006.00588.x.
  • Becker G, Hess CF, Grund KE, Hoffmann W, Bamberg M. Abdominal wall metastasis following percutaneous endoscopic gastrostomy. Support Care Cancer. 1995;3(5):313–316. Epub 1995/09/01.
  • Wacke W, Hecker U, Woenckhaus C, Lerch MM. Percutaneous endoscopic gastrostomy site metastasis in a patient with esophageal cancer. Endoscopy. 2004;36(05):472–Epub 2004/04. /22. doi: 10.1055/s-2004-814379.
  • Deinzer M, Menges M, Walter K, Puschel W, Braun A, Niewald M. [Implantation metastasis at the exit site after percutaneous endoscopic gastrostomy in esophageal carcinoma]. Z Gastroenterol. 1999;37(9):789–793. Epub 1999/10/16.
  • Greaves JR. Head and neck cancer tumor seeding at the percutaneous endoscopic gastrostomy site. Nutr Clin Pract. 2018;33(1):73–80. Epub 2018/01/13. doi: 10.1002/ncp.10021.
  • Nagaraja V, Cox MR, Eslick GD. Safety and efficacy of esophageal stents preceding or during neoadjuvant chemotherapy for esophageal cancer: a systematic review and meta-analysis. J Gastrointest Oncol. 2014;5(2):119–126. Epub 2014/04/29. PubMed PMID: 24772340; PubMed Central PMCID: PMCPMC3999625. doi: 10.3978/j.issn.2078-6891.2014.007.
  • Gomes GF, Pisani JC, Macedo ED, Campos AC. The nasogastric feeding tube as a risk factor for aspiration and aspiration pneumonia. Curr Opin Clin Nutr Metab Care. 2003;6(3):327–333. Epub 2003/04/12. doi: 10.1097/01.mco.0000068970.34812.8b.
  • Stockeld D, Fagerberg J, Granstrom L, Backman L. Percutaneous endoscopic gastrostomy for nutrition in patients with oesophageal cancer. Eur J Surg. 2001;167(11):839–844. Epub 2002/02/19. doi: 10.1080/11024150152717670.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.